title: Immunology of gut mucosal vaccines.
abstract: Understanding the mechanisms underlying the induction of immunity in the gastrointestinal mucosa following oral immunization and the cross-talk between mucosal and systemic immunity should expedite the development of vaccines to diminish the global burden caused by enteric pathogens. Identifying an immunological correlate of protection in the course of field trials of efficacy, animal models (when available), or human challenge studies is also invaluable. In industrialized country populations, live attenuated vaccines (e.g. polio, typhoid, and rotavirus) mimic natural infection and generate robust protective immune responses. In contrast, a major challenge is to understand and overcome the barriers responsible for the diminished immunogenicity and efficacy of the same enteric vaccines in underprivileged populations in developing countries. Success in developing vaccines against some enteric pathogens has heretofore been elusive (e.g. Shigella). Different types of oral vaccines can selectively or inclusively elicit mucosal secretory immunoglobulin A and serum immunoglobulin G antibodies and a variety of cell-mediated immune responses. Areas of research that require acceleration include interaction between the gut innate immune system and the stimulation of adaptive immunity, development of safe yet effective mucosal adjuvants, better understanding of homing to the mucosa of immunologically relevant cells, and elicitation of mucosal immunologic memory. This review dissects the immune responses elicited in humans by enteric vaccines.
authors.affiliation: Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore St., Room 480, Baltimore, MD 21201, USA. mpasetti@medicine.umaryland.edu
authors.forename: Marcela F
authors.initials: MF
authors.lastname: Pasetti
authors.forename: Jakub K
authors.initials: JK
authors.lastname: Simon
authors.forename: Marcelo B
authors.initials: MB
authors.lastname: Sztein
authors.forename: Myron M
authors.initials: MM
authors.lastname: Levine
mesh_terms: D000276:Adjuvants, Immunologic; D000284:Administration, Oral; D004756:Enterobacteriaceae Infections / Q000276:immunology / Q000517:prevention & control; D041981:Gastrointestinal Tract / Q000276:immunology*; D006801:Humans; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D007074:Immunoglobulin G; D007413:Intestinal Mucosa / Q000276:immunology*; D011055:Poliovirus Vaccine, Oral / Q000276:immunology; D022243:Rotavirus Vaccines / Q000276:immunology; D014612:Vaccines / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D011055:Poliovirus Vaccine, Oral; D022243:Rotavirus Vaccines; D014612:Vaccines; D014613:Vaccines, Attenuated